Keros Therapeutics(KROS) - 2020 Q4 - Annual Report
Keros Therapeutics(KROS)2021-03-25 12:23UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________ FORM 10-K ________________________________________ (Mark One) ________________________________________ KEROS THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) ________________________________________ Delaware 81-1173868 (State or other jurisdiction of incorporation or organization) 99 Hayden Avenue, Suite 120, Building E (I.R.S. Employer Identification Number) 02421 Lexing ...